INS and metabolic dysfunction-associated steatotic liver disease: In a randomized controlled clinical trial addressing weight loss and metabolic status among NAFLD participants from Iran, consumption of a DASH diet for 8 weeks had a beneficial effect on body weight and metabolic profiles, including liver enzymes, triglycerides, insulin metabolism markers, inflammatory markers, and oxidative stress markers [44].